Trimetazidine reverses calcium accumulation and impairment of phosphorylation induced by cyclosporine A in isolated rat liver mitochondria

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 1, 1996, Pages 417-422

  Salducci, M D ^a   Chauvet Monges, A M ^a   Tillement, J P ^b   Albengres, E ^b   Testa, B ^c   Carrupt, P ^c   Crevat, A ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Service de Bactériologie   (France)

^c Inst de Chimie Thérapeutique   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL; CYCLOSPORIN A; TRIMETAZIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL ISOLATION; DOSE RESPONSE; LIVER MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; MALE; MITOCHONDRIA, LIVER; OXIDATIVE PHOSPHORYLATION; RATS; RATS, WISTAR; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 0030430051     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ABRAHAM, J. S., BENTLEY, F. R., GARRISON, R N. AND CRYER, H. M.: Cyclosporine A directly constricts intrarenal arterioles. Transplant. Proc. 23: 356-359, 1991.
2. BROEKEMEIER, K. M., DEMPSEY, M. E. AND PFEIFFER, D. R.: Cyclosporine A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264: 7826-7830, 1989.
3. CREAGH, T., LANIGAN, D., DOLAN, J., TORMEY, W., WALSHE, J. J. AND BOUCHIER-HAYES, D.: Pharmacological manipulation of acute cyclosporin ischemic renal injury with trimetazidine. J. Urol. 149: 915-917, 1993.
4. ++ dependent pore in heart mitochondria activated by inorganic phosphate and oxidation stress. Biochem. J. 255: 357-360, 1988.
5. CRUZ, C., ZAOUI, A., AYOUB, S., HARPEY, C., GOUPIT, P. AND YOUNES, A.: Altérations des myocytes isolés des ventricules de coeur de rat adulte: Protection par la trimétazidine. Concours Med. 36 (Suppl.): 3470-3475, 1987.
6. DETRY, J. M., SELLIER, P., PENNAFORTE, S., COKKINOS, D., DARGIE, H. AND MATHES, P.: Trimetazidine: A new concept in the treatment of angina: Comparison with propranolol in patients with stable angina. Br. J. Clin. Pharmacol. 37: 279-288, 1994.
7. DUCHEN, M. R., MC GUINESS, O., BROWN, L. A. AND CROMPTON M.: On the involvement of a cyclosporine A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc. Res. 27: 1790-1794, 1993.
8. FOLEY, R. J., HAMMER, R. W. AND WEINMAN E. J.: Serum potassium concentrations in cyclosporine and azathioprine-treated renal transplant patients. Nephron 40: 280-285, 1985.
9. FOURNIER, N., DUCET, G. AND CREVAT, A.: Action of cyclosporine A on mitochondrial calcium fluxes. J. Bioenerg. Biomembr. 19: 297-303, 1987.
10. GUARNIERI, C. AND MUSCARI, C.: Effect of trimetazidine on mitochondrial functions and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology 46: 324-331, 1993.
11. GUNTER, T. E., GUNTER, K. K., SHEU, S. S. AND GAVIN, C. E.: Mitochondrial calcium transport: Physiological and pathological relevance. Am. J. Physiol. 267: C313-C339, 1994.
12. GOGVADZE, V. AND RICHTER, C.: Cyclosporine A protects mitochondria in an in vitro model of hypoxia/reperfusion injury. FEBS Lett. 333: 334-338, 1993.
13. HARPEY, C., CLAUSER, P., LABRID, C., FREYRIA, J. L. AND POIRIER, J. P.: Trimetazidine, a cellular anti-ischemic agent. Cardiovasc. Drug Rev. 6: 292-312, 1989.
14. ++ overload in primary cultures of rat renal cortical epithelial cells by cytotoxic concentrations of cyclosporine: A digitized fluorescence imaging study. Toxicology. 95: 155-166, 1995.
15. JOHNSON, G. AND LARDY, H.: Isolation of liver or kidney mitochondria, in Methods in Enzymology, ed by P. W. Estabroock and M. Pullman, p 94-96 Academic Press N. Y., 1967.
16. KASS, G. E. N., JUEDES, M. J. AND ORRENIUS, S.: Cyclosporine A protects hepatocytes against prooxidant-induced cell killing. Biochem. Pharmacol. 44: 1995-2003, 1992.
17. LAVANCHY, N., MARTIN, J. AND ROSSI, A.: Antiischemic effect of Trimetazidine: P-31 NMR spectroscopy in the isolated rat heart. Arch. Int. Pharmacodyn. Ther. 286: 97-110, 1987.
18. MCNALLY, P. G. AND FEEHALLY, J.: Pathophysiology of Cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol. Dial. Transplant 7: 791-804, 1992.
19. MIHATSCH, M. J., THIEL, G. AND RYFFEL, B.: Histopathology of cyclosporine nephrotoxicity. Transplant. Proc. 20: 759-771, 1988.
20. MYERS, B. D.: Cyclosporine nephrotoxicity. Kidney Int. 30: 964-974, 1986.
21. NAITO, S.: Trimetazidine in blood, bile, organs and urine. Chem. Pharm. Bull. (Tokyo) 20: 632-638, 1972.
22. NOVGORODOV, S A., GUDZ, T. I., MILGROM, Y. M. AND BRIERLEY, G. P.: The permeability transition in heart mitochondria is regulated synergistically by ADP and cyclosporine A. J. Biol. Chem. 267: 16274-16282, 1992.
23. ORRENIUS, S., KASS, G. E. N., DUDDY, S. K. AND NICOTERA, P.: Molecular mechanisms of oxidative cell damage. In Biological Oxidation Systems, ed. by C. C. Reddy, G. A. Hamilton and K M. Madyastha, p 965-975, Academic Press, New York, 1990.
24. ++ from mitochondria without inactivating the mitochondrial inner-membrane pore. Biochem. J. 297: 151-155, 1994.
25. RICHTER, C. AND SCHLEGEL, J.: Mitochondrial calcium release induced by prooxidants. Toxicol. Lett. 67: 119-127, 1993.
26. RICHTER, C., THEUS, M. AND SCHLEGEL, J.: Cyclosporine A inhibits mitochondrial pyridine nucleotide hydrolysis and calcium release. Biochem. Pharmacol. 40: 779-782, 1990.
27. SALDUCCI, D., CHAUVET-MONGES, A. M., BERLAND, Y., DUSSOL, B., ELSEN, R. AND CREVAT, A.: The restoration of ATP synthesis may explain the protective effect of calcium antagonists against cyclosporine A nephrotoxicity. Life Sci. 50: 2053-2058, 1992.
28. SCHLEGEL, J., MEIER, P., KASS, G. E. N. AND RICHTER, C.: Inhibition by cyclosporine A of the prooxidant-induced but not of the sodium-induced calcium release from rat kidney mitochondria. Biochem. Pharmacol. 42: 2193-2197, 1991.
29. ++. Biochim. Biophys. Acta 592: 396-405, 1980.
30. URIEN, S.: Micropharm: Software designed to analyze pharmacological data from pharmacokinetic, binding and tissue extraction experiments. Bull. Cancer 78: 654, 1991.